Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Tadvalkar Laura — Cidara Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Tadvalkar Laura

Tadvalkar Laura

Director at Cidara Therapeutics, Inc. · on record since Apr 30, 2024
Director at Hemab Therapeutics Holdings, Inc. · on record since Apr 30, 2026

Insider trading activity of Tadvalkar Laura

Transactions on record: 2; since Apr 30, 2024

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jul 19, 2024

Figures computed from official regulatory filings — methodology.

Companies where Tadvalkar Laura has traded

Cidara Therapeutics, Inc.2 tx · Jul 19, 2024

Track record of Tadvalkar Laura

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Tadvalkar Laura

Co-insiders of Tadvalkar Laura

Kolchinsky PeterCidara Therapeutics, Inc. +1
RA Capital Biotech Fund LPCidara Therapeutics, Inc. +1
RA CAPITAL MANAGEMENT, LLCCidara Therapeutics, Inc. +1
Shah Rajeev M.Cidara Therapeutics, Inc. +1
5AM Co-Investors III, L.P.Cidara Therapeutics, Inc.
5AM VENTURES III, L.P.Cidara Therapeutics, Inc.
Abdollahian NeilCidara Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Access Industries Holdings LLCHemab Therapeutics Holdings, Inc.

ACCESS INDUSTRIES MANAGEMENT, LLCHemab Therapeutics Holdings, Inc.

AI Biotechnology LLCHemab Therapeutics Holdings, Inc.

AI DEN-MAB LLCHemab Therapeutics Holdings, Inc.

Aisling Capital II LPCidara Therapeutics, Inc.

AISLING CAPITAL PARTNERS LLCCidara Therapeutics, Inc.

AISLING CAPITAL PARTNERS, LPCidara Therapeutics, Inc.

Bain LindaHemab Therapeutics Holdings, Inc.

Bartizal KenCidara Therapeutics, Inc.

Bassler Bonnie LCidara Therapeutics, Inc.

BB BIOTECH AGCidara Therapeutics, Inc.

Behrndt-Eriksen Mads NikolajHemab Therapeutics Holdings, Inc.

BIOTECH TARGET N VCidara Therapeutics, Inc.

Blavatnik LenHemab Therapeutics Holdings, Inc.

BURGESS DANIEL DCidara Therapeutics, Inc.

Canale-Theakston CarinCidara Therapeutics, Inc.

Daruwala PaulCidara Therapeutics, Inc.

Davarpanah Nicole NegarCidara Therapeutics, Inc.

DIEKMAN JOHN DCidara Therapeutics, Inc.

ELMS STEVECidara Therapeutics, Inc.

Forrest KevinCidara Therapeutics, Inc.

Franson Timothy RCidara Therapeutics, Inc.

Gollaher David LCidara Therapeutics, Inc.

Heron Patrick JCidara Therapeutics, Inc.

Johnson BradyCidara Therapeutics, Inc.

Judice KevinCidara Therapeutics, Inc.

KARBE FRANKCidara Therapeutics, Inc.

Kjellson Nina SCidara Therapeutics, Inc.

Levine James E.Cidara Therapeutics, Inc.

Madigan CatherineHemab Therapeutics Holdings, Inc.

MARAGANORE JOHNHemab Therapeutics Holdings, Inc.

Merson JamesCidara Therapeutics, Inc.

Mineo ChrysaCidara Therapeutics, Inc.

Mundipharma AGCidara Therapeutics, Inc.

Murthy Ananthram SreenivasaHemab Therapeutics Holdings, Inc.

Novo A/SHemab Therapeutics Holdings, Inc.

Oien JessicaCidara Therapeutics, Inc.

Onaitis MatthewCidara Therapeutics, Inc.

PEREZ ROBERT JCidara Therapeutics, Inc.

Purcell Dennis JCidara Therapeutics, Inc.

RA Capital Nexus Fund II, L.P.Hemab Therapeutics Holdings, Inc.

RA Capital Nexus Fund IV, L.P.Hemab Therapeutics Holdings, Inc.

Resnick JoshuaCidara Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Cidara Therapeutics, Inc.	Jul 19, 2024	AwardD	2,125	0.00 USD	$0	SEC
Cidara Therapeutics, Inc.	Apr 30, 2024	AwardD	4,250	0.00 USD	$0	SEC